Please Wait
Applying Filters...
menu
    • menu
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Emedastine Difumarate

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1Shiratori Pharmaceutical Co., Ltd.@Nipro Pharma Corporation

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Shiratori Pharmaceutical

    Japan
    PCC
    Not Confirmed
    arrow

    Shiratori Pharmaceutical

    Japan
    arrow
    PCC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Emedastine fumarate sustained-release granules

    Registrant Name : Kolon Pharmaceutical Co., Ltd.

    Registration Date : 2022-02-08

    Registration Number : 20220208-209-J-1230

    Manufacturer Name : Shiratori Pharmaceutical Co....

    Manufacturer Address : 54 Shinminato, Mihama-ku, Chiba-shi, Chiba, Japan@2-1, Minamisakae-cho, Kasukabe-shi,...

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Looking for 87233-62-3 / Emedastine Fumarate API manufacturers, exporters & distributors?

    Emedastine Fumarate manufacturers, exporters & distributors 1

    86

    PharmaCompass offers a list of Emedastine Fumarate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Emedastine Fumarate manufacturer or Emedastine Fumarate supplier for your needs.

    Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Emedastine Fumarate manufacturer or Emedastine Fumarate supplier.

    API | Excipient name

    Emedastine Fumarate

    Synonyms

    87233-62-3, Rapimine, Kb-2413, Al-3432a, Daren, 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidazole difumarate

    Cas Number

    87233-62-3

    Unique Ingredient Identifier (UNII)

    42MB94QOSM

    About Emedastine Fumarate

    Emedastine Difumarate is the difumarate salt form of emedastine, a second generation, selective histamine H1 receptor antagonist with anti-allergic activity. Emedastine reversibly and competitively blocks histamine by binding to H1 receptors, thus blocking its downstream activity. As a result, this agent interferes with mediator release from mast cells either by inhibiting calcium ion influx across mast cell/basophil plasma membrane or by inhibiting intracellular calcium ion release within the cells. In addition, emedastine may also inhibit the late-phase allergic reaction mediated through leukotrienes or prostaglandins, or by producing an anti-platelet activating factor effect. Upon ocular administration, emedastine causes a dose-dependent inhibition of histamine-stimulated vascular permeability in the conjunctiva. Emedastine does not affect adrenergic, dopamine, or serotonin receptors.

    Emedastine Difumarate Manufacturers

    A Emedastine Difumarate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Emedastine Difumarate, including repackagers and relabelers. The FDA regulates Emedastine Difumarate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Emedastine Difumarate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

    click here to find a list of Emedastine Difumarate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.

    Emedastine Difumarate Suppliers

    A Emedastine Difumarate supplier is an individual or a company that provides Emedastine Difumarate active pharmaceutical ingredient (API) or Emedastine Difumarate finished formulations upon request. The Emedastine Difumarate suppliers may include Emedastine Difumarate API manufacturers, exporters, distributors and traders.

    click here to find a list of Emedastine Difumarate suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.

    Emedastine Difumarate KDMF

    In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

    Pharmaceutical companies submit a Emedastine Difumarate Drug Master File in Korea (Emedastine Difumarate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Emedastine Difumarate. The MFDS reviews the Emedastine Difumarate KDMF as part of the drug registration process and uses the information provided in the Emedastine Difumarate KDMF to evaluate the safety and efficacy of the drug.

    After submitting a Emedastine Difumarate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Emedastine Difumarate API can apply through the Korea Drug Master File (KDMF).

    click here to find a list of Emedastine Difumarate suppliers with KDMF on PharmaCompass.

    Emedastine Difumarate Manufacturers | Traders | Suppliers

    Emedastine Difumarate Manufacturers, Traders, Suppliers 1
    24

    We have 1 companies offering Emedastine Difumarate

    Get in contact with the supplier of your choice:

    1. Shiratori Pharmaceutical
    Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
    For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.